02325.HK
Yunkang Group Limited
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 0.51
−3.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 44.45x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.22x
- Price / sales
- 0.43x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- -HKD 873.4M
- EV / sales
- -1.24x
- EV / EBITDA
- -7.04x
- EV / EBIT
- -22.72x
- Market cap
- HKD 298.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025